|
ALEXANDER
CUTLER Lead Independent Director EDWARD BREEN ELLEN KULLMAN Chair of the
Board & Chief Executive Officer LAMBERTO ANDREOTTI JAMES GALLOGLY
MARILLYN HEWSON ELEUTHÈRE DU PONT ROBERT BROWN, PH.D. ULF MARK SCHNEIDER
PATRICK WARD LEE THOMAS LOIS JULIBER 1 Total Shareholder Return measured from
12/31/08 12/31/14. Calculated as the appreciation or depreciation of share
price, plus any dividends, over a given period, expressed as a percentage of
the shares value at the beginning of the period. Assumes dividends are
re-invested at the closing price applicable on the ex-dividend date. Source:
Datastream. Proxy Peers: 3M, Air Products, Baxter Intl, Boeing, Caterpillar,
Dow Chemical, Emerson, Honeywell, Ingersoll-Rand, Johnson Controls, Johnson
and Johnson, Kimberly Clark, Merck, Monsanto, Procter and Gamble, Syngenta
AG, and United Technologies. TSR reported on a market cap weighted basis.
Closing prices are adjusted for spin-offs, stock splits, rights and special
dividends. 2 From the November 2014 issue of The Harvard Business Review. 3
Awarded by American Institute of Chemical Engineers. 4 Director performance
metrics from Thomson Reuters Datastream and public filings; Total shareholder
return calculated from undisturbed date prior to assuming role through
12/31/2014, or until he/she no longer held the position, whichever was
sooner. Gallogly total shareholder return calculated from April 28, 2010 (the
first trade date for LyondellBasell after its emergence from bankruptcy)
through September 29, 2014 (the date one day prior to the date that the
company announced Mr. Galloglys intent to retire). FORWARD LOOKING
STATEMENTS This document contains forward-looking statements which may be
identified by their use of words like plans, expects, will, believes,
intends, estimates, anticipates or other words of similar meaning. All
statements that address expectations or projections about the future,
including statements about the companys strategy for growth, product
development, regulatory approval, market position, anticipated benefits of
recent acquisitions, timing of anticipated benefits from restructuring
actions, outcome of contingencies, such as litigation and environmental
matters, expenditures and financial results, are forward looking statements.
Forward-looking statements are not guarantees of future performance and are
based on certain assumptions and expectations of future events which may not
be realized. Forward-looking statements also involve risks and uncertainties,
many of which are beyond the companys control. Some of the important factors
that could cause the companys actual results to differ materially from those
projected in any such forward-looking statements are: fluctuations in energy
and raw material prices; failure to develop and market new products and
optimally manage product life cycles; ability to respond to market
acceptance, rules, regulations and policies affecting products based on
biotechnology; significant litigation and environmental matters; failure to
appropriately manage process safety and product stewardship issues; changes
in laws and regulations or political conditions; global economic and capital
markets conditions, such as inflation, interest and currency exchange rates;
business or supply disruptions; security threats, such as acts of sabotage,
terrorism or war, weather events and natural disasters; ability to protect
and enforce the companys intellectual property rights; successful
integration of acquired businesses and separation of underperforming or
non-strategic assets or businesses and successful completion of the proposed
spinoff of the Performance Chemicals segment including ability to fully
realize the expected benefits of the proposed spinoff. The company undertakes
no duty to update any forward-looking statements as a result of future
developments or new information. ADDITIONAL INFORMATION AND WHERE TO FIND IT
DuPont has filed a definitive proxy statement with the U.S. Securities and
Exchange Commission (the SEC) with respect to the 2015 Annual Meeting.
DUPONT STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY
STATEMENT (INCLUDING ANY AMENDMENTS AND SUPPLEMENTS), THE ACCOMPANYING WHITE
PROXY CARD AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY
BECAUSE THEY CONTAIN IMPORTANT INFORMATION. DuPont, its directors, executive
officers and other employees may be deemed to be participants in the
solicitation of proxies from DuPont stockholders in connection with the
matters to be considered at DuPonts 2015 Annual Meeting. Information about
DuPonts directors and executive officers is available in DuPonts definitive
proxy statement, filed with the SEC on March 23, 2015, for its 2015 Annual
Meeting. To the extent holdings of DuPonts securities by such directors or
executive officers have changed since the amounts printed in the proxy
statement, such changes have been or will be reflected on Statements of
Change in Ownership on Form 4 filed with the SEC. Information regarding the
identity of potential participants, and their direct or indirect interests,
by security holdings or otherwise, is set forth in the definitive proxy
statement and, to the extent applicable, will be updated in other materials
to be filed with the SEC in connection with DuPonts 2015 Annual Meeting.
Stockholders will be able to obtain any proxy statement, any amendments or
supplements to the proxy statement and other documents filed by DuPont with
the SEC free of charge at the SECs website at www.sec.gov. Copies also will
be available free of charge at DuPonts website at www.dupont.com or by
contacting DuPont Investor Relations at (302) 774-4994. This is a critical
moment in DuPonts history. We are in the midst of a major transformation,
and we strongly believe that we have the right Board and the right strategy
to shape the next generation DuPont and continue building value for you, our
shareholders. Trian is asking you to replace your highly qualified directors
with their hand-picked nominees who not only lack the skills required to
advance the successful work underway at DuPont but are also singularly
focused on pursuing Trians high-risk, value-destructive agenda. TO PROTECT
THE VALUE OF YOUR INVESTMENT IN DUPONT, PLEASE VOTE THE WHITE PROXY CARD
TODAY. Thank you for your support. Sincerely,
|